February 25, 2015 03:00 AM Eastern Daylight Time
LAFAYETTE, Calif. — Providence Medical Technology, Inc. announced today it has obtained a CE Mark for its DTRAX Spinal System, DTRAX Cervical Cage, and DTRAX Bone Screw. This regulatory approval expands the company’s international product offering to include its entire DTRAX portfolio. Continue Reading
COOPER CITY, FL. Sept 15, 2014 – SafeWire, Inc. a medical device company focused on improving minimally invasive spine surgery, announced today the introduction of its TigerTM Pedicle Access Needle family.
Building upon the award winning Y-Wire® anchoring guide wire for percutaneous spinal pedicle screw delivery, the TigerTM Pedicle Access Needle family features patented platform technology designed to increase the accuracy and ease of MIS pedicle access. It provides surgeons with unparalled control of pedicle access needle advancement, measured and adjustable guide wire deployment, streamlined pedicle preparation, and atraumatic mechanical access needle removal. Four different models ensure a fit with surgeons’ varying needs for control, efficiency and speed
Safewire, LLC (Cooper City, FL) selected Flambeau Medical Markets Group to produce the company’s Tiger Needle family of advanced percutaneous pedicle access devices. The Safewire development team interviewed approximately one dozen manufacturers with the required expertise to produce the product. “What stands out about Flambeau is its spirit of entrepreneurship. It understands the needs of a high growth company competing in the Medtech industry,” commented Safewire’s CEO Wyatt Geist.
LAFAYETTE, Calif. — (BUSINESS WIRE) — Providence Medical Technology, Inc. today announced that the U.S. Patent and Trademark Office issued patents 8,834,530, Cervical Distraction Method; 8,834,472, Vertebral Joint Implants and Delivery Tools, and 8,828,062, Vertebral Joint Implants and Delivery Tools to the company in September 2014
Jupiter, Florida – Providence Medical Technology (PMT), a San Francisco Area medical device startup and Medvest Fund One portfolio company, today announced the issuance of its fifth U.S. patent in 12 months. This brings PMT’s portfolio of issued patents to seven. Continue Reading
Jupiter, Florida – Providence Medical Technology, a San Francisco Area medical device startup and Medvest Fund One portfolio company, has had a busy month. It announced today that two-year follow-up data on patients treated with its DTRAX Facet System will be presented at the annual meeting of the Congress of Neurological Surgeons in San Francisco, October 19-23. These data support the durable safety and efficacy of indirect decompression for the treatment of cervical radiculopathy when using the DTRAX Facet System. Continue Reading
Jupiter, Florida – Stanmore Medical Investments is pleased to announce that MedVest Fund One has invested into Bay Area based Providence Medical Technology. MedVest Fund One’s investment will support Providence’s U.S. launch of its full DTRAX product portfolio. .
Stanmore Medical Investments is pleased to announce that Safewire, a Medvest Fund One portfolio company, was an industry sponsor for the 4th Annual One Spine Residents and Fellows Course at the prestigious Swedish Neuroscience Institute in Seattle, WA, held over the weekend of August 16-18. In collaboration with renowned faculty, Safewire provided training in the principals of minimally invasive spine surgery to an international group of senior surgical residents and spine fellows.
West Palm Beach Florida – Stanmore Medical Investments (“SMI”) is pleased to announce it closed a transaction today in which Medvest Fund One invested $1.1 million for newly issued common membership units from Safewire LLC. The deal is the first transaction closed by SMI on behalf of the current Medvest Fund. It is consistent with the Fund’s allocation strategy among medical device operating companies and other healthcare related early stage ventures. Continue Reading
West Palm Beach, FL. – Stanmore Medical Investments announced today its intentions to commit capital to the medical device industry. SMI will be making investments of $250,000 to $2,000,000 in early to growth stage start-ups addressing unmet needs in the neurosurgical, orthopedic and gastroenterological specialties. Continue Reading